why choose us

First received: July 13, 2023

Clinical Trial: A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Focal Segmental Glomerulosclerosis (FSGS)

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open Label, Randomized, Crossover Study Evaluating the Relative Bioavailability and Food Effect of a VX-147 Test Tablet Formulation Compared to a Reference Tablet Formulation in Healthy Adu

Brief Summary: The purpose of the study is to evaluate the relative bioavailability (BA) and the effect of food on the pharmacokinetics (PK), and the safety and tolerability of VX-147 test tablet formulation.

Read more